We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Alphatec Holdings
ATEC
$1.44B
| $2.08M | ﹤0.01% |
237,933
-6,109
| -3% | -$48.3K |
|
2352
Hackett Group
HCKT
$287M
| $2.07M | ﹤0.01% |
116,956
-1,097
| -0.9% | -$22.3K |
|
2353
Nektar Therapeutics
NKTR
$2.58B
| $2.07M | ﹤0.01% |
43,162
-850
| -2% | -$50.6K |
|
2354
Bar Harbor Bankshares
BHB
$666M
| $2.07M | ﹤0.01% |
78,052
+15,114
| +24% | +$425K |
|
2355
Bank of Marin Bancorp
BMRC
$459M
| $2.07M | ﹤0.01% |
69,082
+312
| +0.5% | +$9.92K |
|
2356
DMC Global
BOOM
$157M
| $2.07M | ﹤0.01% |
129,499
+11,711
| +10% | +$238K |
|
2357
Crescent Energy
CRGY
$3.82B
| $2.07M | ﹤0.01% |
153,389
-39,880
| -21% | -$584K |
|
2358
Helix Energy Solutions
HLX
$1.41B
| $2.06M | ﹤0.01% |
534,721
-16,049
| -3% | -$60.8K |
|
2359
Safe Bulkers
SB
$774M
| $2.06M | ﹤0.01% |
835,591
+3,233
| +0.4% | +$10.9K |
|
|
INBX
2360
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.06M | ﹤0.01% |
114,916
-491
| -0.4% | -$8.85K |
|
|
GDEN
2361
DELISTED
Golden Entertainment
GDEN
| $2.06M | ﹤0.01% |
59,075
-999
| -2% | -$39.9K |
|
2362
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $2.06M | ﹤0.01% |
64,908
+5,697
| +10% | +$191K |
|
2363
Dyne Therapeutics
DYN
$4.9B
| $2.05M | ﹤0.01% |
161,666
-39,022
| -19% | -$447K |
|
2364
ACM Research
ACMR
$5.79B
| $2.05M | ﹤0.01% |
164,429
-3,158
| -2% | -$51.4K |
|
2365
Viridian Therapeutics
VRDN
$2.67B
| $2.05M | ﹤0.01% |
102,749
+43,834
| +74% | +$788K |
|
2366
First Community Bankshares
FCBC
$911M
| $2.05M | ﹤0.01% |
63,950
-2,016
| -3% | -$63.8K |
|
2367
Life Time Group Holdings
LTH
$9.79B
| $2.05M | ﹤0.01% |
210,025
+65,353
| +45% | +$866K |
|
2368
Usana Health Sciences
USNA
$286M
| $2.04M | ﹤0.01% |
36,381
-153
| -0.4% | -$10.1K |
|
|
PNT
2369
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.03M | ﹤0.01% |
263,112
-2,035
| -0.8% | -$17.3K |
|
|
BFS
2370
Saul Centers
BFS
$841M
| $2.02M | ﹤0.01% |
53,956
+4,302
| +9% | +$198K |
|
2371
Barrett Business Services
BBSI
$804M
| $2.02M | ﹤0.01% |
103,536
-1,180
| -1% | -$23.6K |
|
|
ESPR
2372
DELISTED
Esperion Therapeutics
ESPR
| $2.02M | ﹤0.01% |
301,359
+106,392
| +55% | +$731K |
|
2373
LivePerson
LPSN
$32.3M
| $2.02M | ﹤0.01% |
14,270
-2,554
| -15% | -$489K |
|
|
TCS
2374
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.01M | ﹤0.01% |
27,402
+14,817
| +118% | +$1.49M |
|
|
INST
2375
DELISTED
Instructure Holdings, Inc.
INST
| $2.01M | ﹤0.01% |
90,369
-49,820
| -36% | -$1.16M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.